5 federal healthcare updates

Here are five federal healthcare updates Becker’s has reported on since Jan. 11:

Advertisement

1. Congressional leaders are calling for more oversight of telehealth company ads promoting prescription drugs without risk disclosures and for uses that aren’t FDA approved.

2. The U.S. may see a higher amount of flu cases this season compared to past years, preliminary CDC estimates suggest. 

3. First lady Jill Biden was diagnosed with basal cell carcinoma, a common and treatable form of skin cancer.

4. HHS outlined three dates for the implementation of the Inflation Reduction Act, a sweeping drug pricing bill that President Joe Biden signed in 2022.

5. HHS extended the COVID-19 public health emergency until April 11.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.